Resources:
  1. Chaudhry, S. P., & Stewart, G. C. (2016). Advanced Heart Failure: Prevalence, Natural History, and Prognosis. Heart Failure Clinics12 (3), 323–333.
  2. Diepen, S. V., Katz, J. N., Albert, N. M., Henry, T. D., Jacobs, A. K., Kapur, N. K., … Cohen, M. G. (2017). Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation136 (16).
  3. Eisen, H. J. (2019). Left Ventricular Assist Devices (LVADS): History, Clinical Application and Complications. Korean Circulation Journal49 (7), 568. doi: 10.4070/kcj.2019.0161
  4. Kilic, A., Acker, M., & Atluri, P. (2015). Dealing with surgical left ventricular assist device complications. Journal of Thoracic Disease7 (12), 2158–2164.
  5. Hunt, S. A., & Ea, R. (2002). The REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure. Journal of Cardiac Failure8 (2), 59–60. doi: 10.1054/jcaf.2002.32944
  6. Adamson, RM., et al. “Principles of HeartMate II Implantation to Avoid Pump Malposition and Migration.” Journal of Cardiac Surgery , vol. 30, no. 3, Apr. 2014, pp. 296–299., doi:10.1111/jocs.12478.